BLUEBERRIES MEDICAL CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 CAD | -25.00% |
|
-25.00% | -25.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. The Company is focused on processing and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. It is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The Companyâs subsidiaries include Blueberries Research Corporation (BRC), Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc. (BBV Labs.) and SATIN S.A.S. (SATIN). Blueberries SAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia.
Sector
Drug Retailers
Calendar
15/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -25.00% | 5.86M | |
| +12.24% | 2.77B | |
| -7.65% | 1.37B | |
| +52.96% | 536M | |
| -5.91% | 426M | |
| -5.29% | 94.35M | |
| -20.67% | 79.73M | |
| +32.02% | 55.14M | |
| +19.38% | 54.94M |
- Stock Market
- Equities
- BBM Stock
- News Blueberries Medical Corp.
- Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay
